1. President Trump readying drug pricing executive orders — Roche Tecentriq-Avastin combo fails to hit primary endpoint in ovarian cancer trial — Moderna's COVID vaccine could see $5B or more in sales, say analysts — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Heme???

Discussion in 'GI Path' started by Anonymous, May 20, 2010 at 10:59 PM.

  1. Anonymous

    Anonymous Guest

    Heard you jerks want to get into the Heme business. Better stick with butts, butt-head!!!! Ha ha ha ha .......
     
  2. Anonymous

    Anonymous Guest

    we are being very, very secretive about calling reps and interviewing them, then having them make a blood oath not to tell their friends or coworkers. SSSSSHHHHHHHHHHH. Keep it quiet.
     
  3. Anonymous

    Anonymous Guest

    oh my god there are sooo many heme labs. even the oncologists are disgusted
     
  4. Anonymous

    Anonymous Guest


    No secret, everyone knows...LOL What are they thinking????? Oh yeah, BM doesn't think.
     
  5. Anonymous

    Anonymous Guest

    Interesting comments.

    I suggest that entering into hem/path is a smart move for GI Path based on historical information. Dianon was diversified with urology, derm, and hem as well as US Labs. Both were acquired by LCA for millions (almost $1 billion purchase price between the two of them). Every company seeks means to grow and hem is still a strong market despite how many player compete for the business. More drugs are in Stage 3 Trials targeted at luekemia and/or lymphoma which means more diagnostic tests needed on bone marrow/blood samples. Investors are still purchasing stock or making strategic investments within the hem clinical lab market. GI Path is physician owned, yet there is always room for change (see Ameripath and Quest as a reference).

    If you look at the recent landscape, large companies (GE & Novartis) are buying companies (Clarient & Genoptix) doing hem/path due to the companion diagnostic angle and the CLIA lab model.

    In my opinion, the CEO is following a proven path to success, diversifying the company's risk, and positioning the company for future partnerships and ventures. As a result, the sales force will be well suited for growth and opportunities.

    Service and sales will be the deciding factors for success once a strategy is formulated and launched.
     
  6. Anonymous

    Anonymous Guest

    Of course you have to attract some hemepath to TN. Good luck.
     
  7. Anonymous

    Anonymous Guest

    Issue with Companion Diagnostics is that Big Pharma looks for Big name Pathologists and Companies. With Genoptix and Novartis, thats one angle. If you were a player like Lily, Merck etc, would you look at GI Path for companion Diagnostics? Nooooo would probably at this point start with Clarient with their R&D arm and the GE Healthcare powerhouse behind them. You would avoid Sonic, Labcorp, Quest because they are not viewed as premeir pathology labs.
    Novartis will work with Genoptix and offer them first dibs on any drug related diagnostics.

    These guys just want to grow big enough to sell out and retire..
     
  8. Anonymous

    Anonymous Guest

    How's are the Heme labs coming along Bill?
     
  9. Anonymous

    Anonymous Guest

    Forget the Heme thing. What does everyone think of the new name for the joint? Poplar Healthcare Management? Really? Sounds like a nursing home. Better get ready to sell foley catheters and adult diapers for Bill and the gang once the ACOs have a firm foothold in and put downward pressure on one dimensional comporate labs.
     
  10. Anonymous

    Anonymous Guest

    Group of sharp people and will have some success. BM is a leader, K and T know the landscape, throw in RW and it should go ok.
     
  11. Anonymous

    Anonymous Guest

    Good name... I would change it to POLYP HEALTHCARE MANAGEMENT!!!
     
  12. Anonymous

    Anonymous Guest

    Really ?
     
  13. Anonymous

    Anonymous Guest


    You have got to be kidding!!!!
     
  14. Anonymous

    Anonymous Guest

    Gipp is going down....and fast...they will sell out by end of year....
     
  15. Anonymous

    Anonymous Guest

    What does that mean??
     
  16. Anonymous

    Anonymous Guest

    Hey Spot, How's heme coming along..... ha ha ha ....
     
  17. Anonymous

    Anonymous Guest

    How is RPW doing? Is he still a jerk?
     
  18. Anonymous

    Anonymous Guest

    Turds float sometimes........
     
  19. Anonymous

    Anonymous Guest

    one purpose, one passion.....what a crock of shit,,,,gipp is losing customers faster than bill can invent new names.
     
  20. Anonymous

    Anonymous Guest

    Sounds like Little House on the Prairie..lmao....